CN Patent

CN105916502A — {[5-(3-氯苯基)-3-羟基吡啶-2-羰基]氨基}乙酸的固体形式，其组合物和用途

Assigned to Akebia Therapeutics Inc · Expires 2016-08-31 · 10y expired

What this patent protects

本文提供的是包含{[5‑(3‑氯苯基)‑3‑羟基吡啶‑2‑羰基]氨基}乙酸的固体形式，包含所述固体形式的组合物，制造所述固体形式的方法，以及它们用于治疗各种疾病和/或失调的用途。

USPTO Abstract

本文提供的是包含{[5‑(3‑氯苯基)‑3‑羟基吡啶‑2‑羰基]氨基}乙酸的固体形式，包含所述固体形式的组合物，制造所述固体形式的方法，以及它们用于治疗各种疾病和/或失调的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN105916502A
Jurisdiction
CN
Classification
—
Expires
2016-08-31
Drug substance claim
No
Drug product claim
No
Assignee
Akebia Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.